scholarly journals Risks of mortality in children admitted to the paediatric intensive care unit after haematopoietic stem cell transplantation

2003 ◽  
Vol 121 (6) ◽  
pp. 886-891 ◽  
Author(s):  
Maren Tomaske ◽  
Axel Bosk ◽  
Matthias Eyrich ◽  
Peter Bader ◽  
Dietrich Niethammer
Author(s):  
William M. Townsend ◽  
Emma C. Morris

Patients with haematological malignancies require admission to the intensive care unit (ICU) due to the underlying disease, as a consequence of treatment with chemotherapy or after haematopoietic stem cell transplantation. With an increasing numbers of patients being diagnosed with these diseases and longer survival as treatments improve, the burden on ICU is anticipated to increase. There is compelling evidence that patients should not be denied admission to ICU based on the presence of a haematological malignancy. In this chapter the disease- and treatment-related reasons for ICU admission, outcome, and risk prediction scores for patients with haematological malignancies are discussed.


Sign in / Sign up

Export Citation Format

Share Document